Last Updated on: 27 July, 2024
About the Company - Alpa Laboratories Ltd
Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 112.27 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. Mahendra Singh Chawla | Chairman |
Mr. Paresh Chawla | Managing Director |
Mr. Devendra Baheti | Independent Director |
Mr. Sharad Chand Lunawat | Independent Director |
Mr. Krishna Das Malani | Independent Director |
Mrs. Jyoti Jain | Independent Director |
Mr. Pravin Shah | Director |
Mr. Vitthal Kothana | Director |
Mr. Sanket Baheti | Independent Director |
Mr. Shitul Shah | Whole Time Director |
Mr. Sunil Kumar Valecha | Independent Director |
Mrs. Pratibha Lunawat | Independent Director |
Basic Stock Data of Alpa Laboratories Ltd
Last Updated: July 26, 2024, 11:03 pm
Market Cap | 197 Cr. |
---|
Current Price | 93.4 |
---|
High / Low | 115/68.3 |
---|
Stock P/E | 11.8 |
---|
Book Value | 77.0 |
---|
Dividend Yield | 0.00 % |
---|
ROCE | 13.4 % |
---|
ROE | 11.0 % |
---|
Face Value | 10.0 |
---|
PEG Ratio | 0.33 |
---|
Data Source: screener.in
Alpa Laboratories Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 23.11 | 33.16 | 24.99 | 31.52 | 26.26 | 29.33 | 25.50 | 22.42 | 13.54 | 27.31 | 29.16 | 25.43 | 32.39 |
Expenses | 21.37 | 30.23 | 23.76 | 28.98 | 22.73 | 25.61 | 26.86 | 21.00 | 19.28 | 24.68 | 19.90 | 26.58 | 29.07 |
Operating Profit | 1.74 | 2.93 | 1.23 | 2.54 | 3.53 | 3.72 | -1.36 | 1.42 | -5.74 | 2.63 | 9.26 | -1.15 | 3.32 |
OPM % | 7.53% | 8.84% | 4.92% | 8.06% | 13.44% | 12.68% | -5.33% | 6.33% | -42.39% | 9.63% | 31.76% | -4.52% | 10.25% |
Other Income | 0.87 | 1.18 | 0.64 | 4.26 | 2.70 | 2.20 | 3.72 | 1.61 | 6.38 | 2.69 | -0.76 | 4.47 | 2.95 |
Interest | 0.03 | 0.03 | 0.02 | 0.04 | 0.06 | 0.08 | 0.07 | 0.03 | 0.08 | 0.07 | 0.04 | 0.02 | 0.04 |
Depreciation | 0.29 | 0.31 | 0.35 | 0.31 | 0.42 | 0.43 | 0.50 | 0.34 | 0.36 | 0.10 | 0.53 | 0.28 | 0.49 |
Profit before tax | 2.29 | 3.77 | 1.50 | 6.45 | 5.75 | 5.41 | 1.79 | 2.66 | 0.20 | 5.15 | 7.93 | 3.02 | 5.74 |
Tax % | -0.00% | -0.00% | 235.33% | -0.00% | -0.00% | -0.00% | 304.47% | -0.00% | -0.00% | -0.00% | 41.74% | -0.00% | -0.00% |
Net Profit | 2.29 | 3.77 | -2.03 | 6.45 | 5.75 | 5.41 | -3.66 | 2.66 | 0.20 | 5.14 | 4.62 | 3.03 | 5.74 |
EPS in Rs | 1.09 | 1.79 | -0.96 | 3.07 | 2.73 | 2.57 | -1.74 | 1.26 | 0.10 | 2.44 | 2.20 | 1.44 | 2.73 |
Last Updated: July 10, 2024, 2:53 pm
Alpa Laboratories Ltd Quarterly Chart
Alpa Laboratories Ltd Profit & Loss
Last Updated: July 10, 2024, 2:53 pm
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|
Sales | 55 | 56 | 56 | 57 | 53 | 63 | 62 | 77 | 85 | 97 | 112 | 93 | 114 |
Expenses | 53 | 53 | 51 | 54 | 47 | 56 | 57 | 76 | 79 | 90 | 101 | 85 | 100 |
Operating Profit | 3 | 3 | 6 | 3 | 7 | 7 | 4 | 1 | 6 | 8 | 11 | 8 | 14 |
OPM % | 5% | 5% | 10% | 6% | 13% | 11% | 7% | 2% | 7% | 8% | 10% | 9% | 12% |
Other Income | 1 | 0 | 1 | 2 | 6 | 4 | 5 | 5 | 0 | 4 | 11 | 9 | 9 |
Interest | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 5 | 9 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Profit before tax | 1 | -3 | -5 | -3 | 11 | 9 | 7 | 5 | 5 | 11 | 20 | 16 | 22 |
Tax % | 37% | -36% | -4% | 48% | 27% | 34% | 27% | 36% | 20% | 33% | 28% | 21% | |
Net Profit | 1 | -4 | -5 | -1 | 8 | 6 | 5 | 3 | 4 | 7 | 14 | 13 | 19 |
EPS in Rs | 0.25 | -2.08 | -2.45 | -0.67 | 3.68 | 2.85 | 2.27 | 1.40 | 1.94 | 3.45 | 6.72 | 6.00 | 8.81 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
Alpa Laboratories Ltd Profit & Loss Yearly Chart
Alpa Laboratories Ltd Growth
|
Compounded Sales Growth |
---|
10 Years: | 7% |
5 Years: | 7% |
3 Years: | 4% |
TTM: | 17% |
|
Compounded Profit Growth |
---|
10 Years: | 18% |
5 Years: | 44% |
3 Years: | 48% |
TTM: | 67% |
|
Stock Price CAGR |
---|
10 Years: | 23% |
5 Years: | 40% |
3 Years: | 22% |
1 Year: | 32% |
|
Return on Equity |
---|
10 Years: | 6% |
5 Years: | 7% |
3 Years: | 8% |
Last Year: | 11% |
Last Updated: July 23, 2024, 5:59 pm
Alpa Laboratories Ltd Balance Sheet
Last Updated: July 10, 2024, 2:53 pm
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
---|
Equity Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
Reserves | 77 | 72 | 67 | 66 | 73 | 77 | 82 | 85 | 89 | 96 | 111 | 123 | 132 |
Borrowings | 12 | 17 | 23 | 29 | 24 | 11 | 6 | 2 | 0 | 0 | 6 | 3 | 2 |
Other Liabilities | 20 | 14 | 15 | 13 | 27 | 20 | 17 | 21 | 21 | 33 | 28 | 30 | 39 |
Total Liabilities | 130 | 125 | 127 | 128 | 145 | 129 | 127 | 129 | 131 | 150 | 165 | 178 | 194 |
Fixed Assets | 9 | 80 | 73 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 9 | 7 | 7 |
CWIP | 59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 10 | 22 | 23 | 41 | 59 | 68 | 62 | 86 | 90 | 117 |
Other Assets | 62 | 45 | 54 | 113 | 118 | 100 | 79 | 64 | 56 | 80 | 70 | 81 | 70 |
Total Assets | 130 | 125 | 127 | 128 | 145 | 129 | 127 | 129 | 131 | 150 | 165 | 178 | 194 |
Alpa Laboratories Ltd Reserves and Borrowings Chart
Alpa Laboratories Ltd Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|
Cash from Operating Activity | 3 | 8 | -2 | -25 | -8 | -7 | -1 | 18 | -1 | 2 | 9 | 4 |
Cash from Investing Activity | -4 | -2 | 37 | -7 | 1 | -16 | -15 | -11 | 6 | -16 | 2 | -13 |
Cash from Financing Activity | 2 | 4 | 7 | -6 | -2 | 4 | -5 | -1 | -0 | 5 | -3 | 2 |
Net Cash Flow | 0 | 10 | 42 | -37 | -9 | -19 | -20 | 5 | 4 | -8 | 7 | -7 |
|
Alpa Laboratories Ltd Financial Efficiency Indicators
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Debtor Days | 142 | 127 | 130 | 156 | 234 | 169 | 151 | 141 | 105 | 133 | 124 | 184 |
Inventory Days | 142 | 132 | 148 | 76 | 196 | 131 | 140 | 105 | 90 | 102 | 81 | 84 |
Days Payable | 142 | 85 | 121 | 91 | 244 | 140 | 130 | 99 | 98 | 152 | 78 | 100 |
Cash Conversion Cycle | 142 | 174 | 157 | 141 | 187 | 160 | 161 | 148 | 97 | 83 | 127 | 168 |
Working Capital Days | 265 | 187 | 169 | 178 | 390 | 256 | 234 | 194 | 121 | 137 | 136 | 155 |
ROCE % | 2% | -1% | -3% | 0% | 10% | 11% | 7% | 4% | 7% | 7% | 9% | 9% |
Alpa Laboratories Ltd Financial Efficiency Indicators Chart
Alpa Laboratories Ltd Share Holding Pattern
Month | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|
Promoters | 56.66% | 56.66% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
FIIs | 0.00% | 0.09% | 0.56% | 0.21% | 0.14% | 0.00% | 0.00% | 0.00% | 0.11% | 0.95% | 0.50% | 0.36% |
DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
Government | 0.00% | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Public | 43.34% | 43.20% | 42.15% | 42.50% | 42.56% | 42.70% | 42.70% | 42.70% | 42.59% | 41.74% | 42.21% | 42.35% |
No. of Shareholders | 15,595 | 16,114 | 18,775 | 18,796 | 18,840 | 19,094 | 19,137 | 18,745 | 18,565 | 18,682 | 18,690 | 18,116 |
Alpa Laboratories Ltd Shareholding Pattern Chart
No. of Alpa Laboratories Ltd Shareholders
This stock is not held by any mutual fund
Alpa Laboratories Ltd ROCE Trend
Alpa Laboratories Ltd EPS Trend
Alpa Laboratories Ltd Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 8.01 | 5.88 | 6.70 | 3.44 | 0.88 |
Diluted EPS (Rs.) | 8.01 | 5.88 | 6.70 | 3.44 | 0.89 |
Cash EPS (Rs.) | 8.90 | 6.61 | 7.48 | 4.03 | 2.38 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 72.20 | 63.96 | 57.85 | 51.16 | 47.70 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 72.20 | 63.96 | 57.85 | 51.16 | 47.70 |
Revenue From Operations / Share (Rs.) | 51.68 | 44.18 | 53.36 | 46.36 | 40.86 |
PBDIT / Share (Rs.) | 10.93 | 8.29 | 10.19 | 5.75 | 2.98 |
PBIT / Share (Rs.) | 10.00 | 7.66 | 9.40 | 5.16 | 1.48 |
PBT / Share (Rs.) | 9.83 | 7.55 | 9.30 | 5.13 | 1.38 |
Net Profit / Share (Rs.) | 7.97 | 5.98 | 6.70 | 3.44 | 0.88 |
NP After MI And SOA / Share (Rs.) | 7.97 | 5.98 | 6.70 | 3.44 | 0.88 |
PBDIT Margin (%) | 21.14 | 18.76 | 19.09 | 12.39 | 7.29 |
PBIT Margin (%) | 19.35 | 17.33 | 17.61 | 11.13 | 3.61 |
PBT Margin (%) | 19.01 | 17.09 | 17.42 | 11.05 | 3.38 |
Net Profit Margin (%) | 15.42 | 13.53 | 12.55 | 7.42 | 2.15 |
NP After MI And SOA Margin (%) | 15.42 | 13.53 | 12.55 | 7.42 | 2.15 |
Return on Networth / Equity (%) | 11.04 | 9.34 | 11.57 | 6.73 | 1.84 |
Return on Capital Employeed (%) | 13.63 | 11.90 | 15.97 | 10.07 | 3.08 |
Return On Assets (%) | 9.18 | 7.52 | 9.07 | 5.16 | 1.52 |
Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
Total Debt / Equity (X) | 0.03 | 0.01 | 0.04 | 0.00 | 0.00 |
Asset Turnover Ratio (%) | 0.62 | 0.57 | 0.73 | 0.71 | 0.68 |
Current Ratio (X) | 5.69 | 4.67 | 4.43 | 3.73 | 4.59 |
Quick Ratio (X) | 5.21 | 4.28 | 3.93 | 3.22 | 3.99 |
Inventory Turnover Ratio (X) | 4.78 | 3.73 | 3.96 | 3.73 | 3.72 |
Interest Coverage Ratio (X) | 64.02 | 78.01 | 97.84 | 155.24 | 31.95 |
Interest Coverage Ratio (Post Tax) (X) | 47.71 | 57.27 | 65.32 | 94.03 | 10.45 |
Enterprise Value (Cr.) | 179.04 | 106.65 | 149.57 | 65.56 | 23.69 |
EV / Net Operating Revenue (X) | 1.65 | 1.15 | 1.33 | 0.67 | 0.27 |
EV / EBITDA (X) | 7.79 | 6.11 | 6.98 | 5.42 | 3.78 |
MarketCap / Net Operating Revenue (X) | 1.61 | 1.22 | 1.30 | 0.77 | 0.34 |
Price / BV (X) | 1.16 | 0.84 | 1.20 | 0.70 | 0.29 |
Price / Net Operating Revenue (X) | 1.61 | 1.22 | 1.30 | 0.77 | 0.34 |
EarningsYield | 0.09 | 0.11 | 0.09 | 0.09 | 0.06 |
Alpa Laboratories Ltd Profitability Ratios (%)
Alpa Laboratories Ltd Liquidity Ratios
Alpa Laboratories Ltd Liquidity Ratios (%)
Alpa Laboratories Ltd Interest Coverage Ratios (%)
Alpa Laboratories Ltd Valuation Ratios
Strength and Weakness of Alpa Laboratories Ltd Stock
Strength | Weakness |
---|
- The company has higher reserves (90.17 cr) compared to borrowings (10.50 cr), indicating strong financial stability.
- The company has shown consistent growth in sales (75.38 cr) and profit (7.38 cr) over the years.
| - The stock has a low average ROCE of 5.17%, which may not be favorable.
- The stock has a high average Working Capital Days of 201.83, which may not be favorable.
- The stock has a high average Cash Conversion Cycle of 145.42, which may not be favorable.
|
FAQ
What is the latest fair value of Alpa Laboratories Ltd?
The latest fair value of Alpa Laboratories Ltd is ₹0.00.
What is the Market Cap of Alpa Laboratories Ltd?
The Market Cap of Alpa Laboratories Ltd is 197 Cr..
What is the current Stock Price of Alpa Laboratories Ltd as on 27 July 2024?
The current stock price of Alpa Laboratories Ltd as on 27 July 2024 is 93.4.
What is the High / Low of Alpa Laboratories Ltd stocks in FY 2024?
In FY 2024, the High / Low of Alpa Laboratories Ltd stocks is 115/68.3.
What is the Stock P/E of Alpa Laboratories Ltd?
The Stock P/E of Alpa Laboratories Ltd is 11.8.
What is the Book Value of Alpa Laboratories Ltd?
The Book Value of Alpa Laboratories Ltd is 77.0.
What is the Dividend Yield of Alpa Laboratories Ltd?
The Dividend Yield of Alpa Laboratories Ltd is 0.00 %.
What is the ROCE of Alpa Laboratories Ltd?
The ROCE of Alpa Laboratories Ltd is 13.4 %.
What is the ROE of Alpa Laboratories Ltd?
The ROE of Alpa Laboratories Ltd is 11.0 %.
What is the Face Value of Alpa Laboratories Ltd?
The Face Value of Alpa Laboratories Ltd is 10.0.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a
SEBI registered financial advisor and does not have any vested interest in Alpa Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source:
NSE